Safety and tolerability of nintedanib in patients with interstitial lung diseases in subgroups by sex: a post-hoc analysis of pooled data from four randomised controlled trials
Related Posts
Shannon EM, Chen L, Yuan A, Chary A, Gabrielian S, Eisenman DP, Washington DL. Extreme Heat, Social Factors, and Mortality Among California Veterans With Cardiometabolic[...]
Blanco LR, Choi A, Hays RD. Differences in Retirement Knowledge and Financial Preparedness between Hispanic and Non-Hispanic White Older Adults in the United States. Gerontologist.[...]
Binod M, Chang L, Hung MW, Dong TS, Kilpatrick LA, Tomasevic A, Choy M, Shin A, Mayer EA, Church A. Multi-omics analysis reveal clinical-gut-brain interactions[...]